{"success":true,"data":{"pressRelease":{"id":"26112","rtpr_id":"nACS5dkPya","ticker":"IMMP","exchange":"NASDAQ","all_tickers":["IMMP","IMM"],"title":" IMMP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Immutep Limited Investors with Losses Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","published_at":"2026-05-07T15:00:02.782Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 7,\n2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst Immutep Limited (NASDAQ:IMMP) and certain of its officers.\n(https://app.accessnewswire.com/imagelibrary/0590af5e-c431-4aad-8093-79bb5e8703d2/bronstein-gewirtz-and-grossman-llc.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Immutep securities between March\n24, 2025 and March 12, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/IMMP.\n(https://bgandg.com/IMMP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IMMP)\n\nImmutep Case Details\n\nThe Complaint alleges that, throughout the Class Period, Defendants made\nmaterially false and misleading statements and/or failed to disclose that:\n1.\nDefendants concealed and misrepresented the status and prospects of the\nCompany's TACTI-004 trial by relying on prior positive efficacy and safety\nreadouts of efti in other studies, including TACTI-002 and INSIGHT-003, to\nsuggest continued success;\n2.\nDefendants' statements regarding the TACTI-004 trial's \"strong operational\nprogress\" and the anticipated timing of its interim futility analysis lacked a\nreasonable basis given then-existing clinical data;\n3.\nbased on their access to internal clinical data, analyses, and reports,\nDefendants knew or recklessly disregarded that the risk of the TACTI-004 trial\nfailing to meet its primary efficacy and/or safety endpoints had materially\nincreased; and\n4.\nas a result, Defendants' statements about the Company's business, operations,\nand prospects were materially false and misleading at all relevant times.\n\nWhat's Next for Immutep Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/IMMP.\n(https://bgandg.com/IMMP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IMMP)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in Immutep you have until July 6,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to Immutep Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Immutep Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/immp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1164329)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACS5dkPya","title":" IMMP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Immutep Limited Investors with Losses Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","ticker":"IMMP","created":"2026-05-07T15:00:02.782Z","tickers":["IMMP","IMM"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 7,\n2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst Immutep Limited (NASDAQ:IMMP) and certain of its officers.\n(https://app.accessnewswire.com/imagelibrary/0590af5e-c431-4aad-8093-79bb5e8703d2/bronstein-gewirtz-and-grossman-llc.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Immutep securities between March\n24, 2025 and March 12, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/IMMP.\n(https://bgandg.com/IMMP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IMMP)\n\nImmutep Case Details\n\nThe Complaint alleges that, throughout the Class Period, Defendants made\nmaterially false and misleading statements and/or failed to disclose that:\n1.\nDefendants concealed and misrepresented the status and prospects of the\nCompany's TACTI-004 trial by relying on prior positive efficacy and safety\nreadouts of efti in other studies, including TACTI-002 and INSIGHT-003, to\nsuggest continued success;\n2.\nDefendants' statements regarding the TACTI-004 trial's \"strong operational\nprogress\" and the anticipated timing of its interim futility analysis lacked a\nreasonable basis given then-existing clinical data;\n3.\nbased on their access to internal clinical data, analyses, and reports,\nDefendants knew or recklessly disregarded that the risk of the TACTI-004 trial\nfailing to meet its primary efficacy and/or safety endpoints had materially\nincreased; and\n4.\nas a result, Defendants' statements about the Company's business, operations,\nand prospects were materially false and misleading at all relevant times.\n\nWhat's Next for Immutep Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/IMMP.\n(https://bgandg.com/IMMP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IMMP)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in Immutep you have until July 6,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to Immutep Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Immutep Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/immp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1164329)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-05-07T15:00:02.839729613Z","server_sent_at_ms":1778166002839},"received_at":"2026-05-07T15:00:02.902Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/immp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1164329"},"analysis":{"id":"20449","press_release_id":"26112","analysis_json":{"redFlags":[],"eventType":"legal_litigation","narrative":"Bronstein, Gewirtz & Grossman, LLC announced that a class action lawsuit has been filed against Immutep Limited and certain officers regarding alleged federal securities violations.\n\nThe complaint alleges that the company made false or misleading statements regarding the status and prospects of its TACTI-004 trial, specifically concealing the risk of trial failure.\n\nInvestors who purchased securities between March 24, 2025 and March 12, 2026 are encouraged to join the case, with a lead plaintiff deadline of July 6, 2026.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":["TACTI-004 trial","TACTI-002","INSIGHT-003","efti"],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Immutep Limited","ticker":"IMMP"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bronstein, Gewirtz & Grossman, LLC. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"IMMP"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bronstein, Gewirtz & Grossman, LLC announced that a class action lawsuit has been filed against Immutep Limited and certain officers regarding alleged federal securities violations.\n\nThe complaint alleges that the company made false or misleading statements regarding the status and prospects of its TACTI-004 trial, specifically concealing the risk of trial failure.\n\nInvestors who purchased securities between March 24, 2025 and March 12, 2026 are encouraged to join the case, with a lead plaintiff deadline of July 6, 2026.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":["TACTI-004 trial","TACTI-002","INSIGHT-003","efti"],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Immutep Limited","ticker":"IMMP"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:f66160e0fe5301b2","schema_hash":"sha256:12363694422af5d9","created_at":"2026-05-08T00:24:39.961Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":19878,"modelName":"glm-4.7"}}